Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

19drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: 177Lu-PSMA ×

177Lu-PSMA

This drug is selected. Its supporting articles are shown below.

177Lu-PSMA3

Articles mentioning 177Lu-PSMA

3 articles · page 1 of 1

674 Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving ¹7 7Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune response

jitc · abstract · 2025-11-04 · 10 matching annotations

90.2%

pembrolizumab Nivolumab Ipilimumab 177Lu-PSMA 177Lu-PSMA-617

… reduction in NK and B cells. When 177Lu-PSMA was combined with pembrolizumab, we saw dynamic changes in non-Treg T cell subsets (CD4+ and CD…

Future of radiotheranostics

bmjonc · full text · 2026-07-08 · 7 matching annotations

96.2%

nivolumab 177Lu-PSMA 177Lu-PSMA-617 177Lu-DOTATATE pembrolizumab

…ion-level assessment.86 Similarly, 177Lu-DOTATATE combined with nivolumab has shown tolerability and preliminary activity in pulmonary ne…

3PC-028 Analysis of calibration discrepancies in lutetium-177 radiopharmaceuticals in radiopharmacy

ejhpharm · abstract · 2026-03-18 · 2 matching annotations

95.1%

177Lu-oxodotreotide Pluvicto 177Lu-PSMA Lutetium-177 177Lu metastatic castration-resistant prostate cancer Lutathera inoperable or metastatic gastro-enteropancreatic neuroendocrine tumours

… metastatic castration-resistant prostate cancer and Lutathera (177Lu-oxodotreotide) for inoperable or metastatic gastro-enteropancreatic neuroendo…